Acquisition of Clondalkin Flexible Packaging Group by Egeria

Egeria, the Dutch based private equity firm has signed an agreement to acquire 100% of the shares of Clondalkin Flexible Packaging Group (“Clondalkin”) from an affiliate of Warburg Pincus.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Egeria, the Dutch based private equity firm has signed an agreement to acquire 100% of the shares of Clondalkin Flexible Packaging Group (“Clondalkin”) from an affiliate of Warburg Pincus. Completion of the transaction is expected to occur in Q4 2016.

Clondalkin Flexible Packaging Group (“Clondalkin”) is a global flexible packaging manufacturer focused on delivering high quality innovative packaging solutions.

Clondalkin comprises 11 manufacturing sites in The Netherlands, Germany, Switzerland, United Kingdom and USA supplying over 45 countries globally with a turnover of approximately €400 million.

Egeria has a proven track record in growing and developing international manufacturing businesses both organically and through acquisitions.

Paddy Mullaney, CEO of Clondalkin said “We are delighted to team up with Egeria for the next step of our development plan. Egeria’s experience in supporting businesses will further facilitate and strengthen Clondalkin’s continued development and expansion.

Floris Waage, partner at Egeria, commented: “We are very excited to team up with Clondalkin. The company has a long history of delivering high value added products and putting its customers first. We are committed to supporting Clondalkin and are convinced it has attractive growth opportunities.”

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?